| Page 134 | Aplastic Anemia & MDS International Foundation Return to top.

The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes

Author(s): 
Zhao Z, Wang Z, Li Q, Li W, You Y, Zou P
Primary Author: 
Zhao Z
Journal Title: 
PLoS One
Original Publication Date: 
Jan 2012

Myelodysplastic syndrome (MDS) are a group of progressive, clonal, neoplastic bone marrow disorders characterized by hematopoietic stem cell dysregulation and abnormalities in the immune system. Mesenchymal

Bone Marrow Disease(s): 

Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis

Author(s): 
Zhao Y, Fei C, Zhang X, Zhang Y, Guo J, Gu S, Li X, Chang C
Primary Author: 
Zhao Y
Journal Title: 
Tumour Biol
Original Publication Date: 
Sep 2012

The identification of epigenetically inactivated tumor suppressor genes may shed additional light on the pathogenesis of

Bone Marrow Disease(s): 

Reduced ribosomal RNA expression and increased ribosomal DNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes

Author(s): 
Raval A, Sridhar KJ, Patel S, Turnbull BB, Greenberg PL, Mitchell BS
Primary Author: 
Raval A
Journal Title: 
Blood
Original Publication Date: 
Oct 2012

Bone Marrow Disease(s): 
Share with addtoany.com.